Related Experiment Video
Updated: Jul 14, 2026

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
Genomics and the development of new diagnostics and anti-Candida drugs
Michael Weig1, Alistair J P Brown
1Institute of Medical Microbiology and German National Reference Centre for Systemic Mycoses, University of Goettingen, Kreuzbergring 57, D-37075 Goettingen, Germany. mweig@gwdg.de
Abstract:
Pathogenic Candida species remain a significant medical problem despite the availability of antifungal therapies. Two key issues must be addressed to improve the treatment of life-threatening systemic Candida infections. First, advanced diagnostic tools are required to facilitate the early identification of these infections, when therapeutic intervention is more likely to be effective. Second, improved antifungal therapies are needed. These therapies, which might include combinations of antifungals, need to be less toxic to the patient and more potent in killing a broader range of Candida species. Recent advances in unravelling the genomics of these species should facilitate efforts to achieve these goals. We discuss the contribution of genomics to the development of novel antifungals and new diagnostic tools.
Insights
Genomic insights are crucial for combating pathogenic Candida infections. Advances in genomics will drive the development of better diagnostic tools and more effective antifungal therapies for systemic Candida infections.
Area of Science:
- Medical Mycology
- Genomics
- Infectious Diseases
Background:
- Pathogenic Candida species cause significant life-threatening systemic infections.
- Current antifungal therapies face challenges in efficacy and toxicity.
- Early diagnosis is critical for effective therapeutic intervention.
Purpose of the Study:
- To highlight the role of genomics in addressing challenges in Candida infection treatment.
- To discuss advancements in diagnostic tools for early Candida identification.
- To explore the development of improved, less toxic, and broader-spectrum antifungal therapies.
Main Methods:
- Review of recent advances in Candida genomics.
- Discussion of the application of genomic data to antifungal drug discovery.
- Analysis of how genomics can inform the development of novel diagnostic strategies.
Main Results:
- Genomic research provides a foundation for developing novel antifungal agents.
- Genomic approaches can lead to the creation of improved diagnostic tools for early detection.
- Understanding Candida genomics facilitates the design of more potent and less toxic treatments.
Conclusions:
- Genomics is pivotal in advancing the treatment of systemic Candida infections.
- Future strategies for combating Candida require integration of genomic insights.
- Genomic advancements promise enhanced diagnostics and more effective antifungal therapies.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Automated Microbial Diagnostics
Modern Molecular Taxonomy
The Central Dogma
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
Microorganisms in Medicine and Therapeutics
Genomics
